These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

472 related items for PubMed ID: 28030809

  • 1. Genomic regulation of invasion by STAT3 in triple negative breast cancer.
    McDaniel JM, Varley KE, Gertz J, Savic DS, Roberts BS, Bailey SK, Shevde LA, Ramaker RC, Lasseigne BN, Kirby MK, Newberry KM, Partridge EC, Jones AL, Boone B, Levy SE, Oliver PG, Sexton KC, Grizzle WE, Forero A, Buchsbaum DJ, Cooper SJ, Myers RM.
    Oncotarget; 2017 Jan 31; 8(5):8226-8238. PubMed ID: 28030809
    [Abstract] [Full Text] [Related]

  • 2. Phosphorylated STAT3 (Tyr705) as a biomarker of response to pimozide treatment in triple-negative breast cancer.
    Dees S, Pontiggia L, Jasmin JF, Mercier I.
    Cancer Biol Ther; 2020 Jun 02; 21(6):506-521. PubMed ID: 32164483
    [Abstract] [Full Text] [Related]

  • 3. STAT3 Targets ERR-α to Promote Epithelial-Mesenchymal Transition, Migration, and Invasion in Triple-Negative Breast Cancer Cells.
    Ma JH, Qi J, Lin SQ, Zhang CY, Liu FY, Xie WD, Li X.
    Mol Cancer Res; 2019 Nov 02; 17(11):2184-2195. PubMed ID: 31427441
    [Abstract] [Full Text] [Related]

  • 4. Interaction between STAT3 and GLI1/tGLI1 oncogenic transcription factors promotes the aggressiveness of triple-negative breast cancers and HER2-enriched breast cancer.
    Sirkisoon SR, Carpenter RL, Rimkus T, Anderson A, Harrison A, Lange AM, Jin G, Watabe K, Lo HW.
    Oncogene; 2018 May 02; 37(19):2502-2514. PubMed ID: 29449694
    [Abstract] [Full Text] [Related]

  • 5. Silibinin downregulates MMP2 expression via Jak2/STAT3 pathway and inhibits the migration and invasive potential in MDA-MB-231 cells.
    Byun HJ, Darvin P, Kang DY, Sp N, Joung YH, Park JH, Kim SJ, Yang YM.
    Oncol Rep; 2017 Jun 02; 37(6):3270-3278. PubMed ID: 28440514
    [Abstract] [Full Text] [Related]

  • 6. STAT3 as a potential therapeutic target in triple negative breast cancer: a systematic review.
    Qin JJ, Yan L, Zhang J, Zhang WD.
    J Exp Clin Cancer Res; 2019 May 14; 38(1):195. PubMed ID: 31088482
    [Abstract] [Full Text] [Related]

  • 7. PDSS1-Mediated Activation of CAMK2A-STAT3 Signaling Promotes Metastasis in Triple-Negative Breast Cancer.
    Yu TJ, Liu YY, Li XG, Lian B, Lu XX, Jin X, Shao ZM, Hu X, Di GH, Jiang YZ.
    Cancer Res; 2021 Nov 01; 81(21):5491-5505. PubMed ID: 34408002
    [Abstract] [Full Text] [Related]

  • 8. Eucannabinolide, a novel sesquiterpene lactone, suppresses the growth, metastasis and BCSCS-like traits of TNBC via inactivation of STAT3.
    Zhu Z, Yuan J, Xu X, Wei Y, Yang B, Zhao H.
    Neoplasia; 2021 Jan 01; 23(1):36-48. PubMed ID: 33217668
    [Abstract] [Full Text] [Related]

  • 9. Obesity-associated metabolic inflammation promotes triple-negative breast cancer progression through the interleukin-6/STAT3/pentraxin 3/matrix metalloproteinase 7 axis.
    Xie H, Ruan G, Wei L, Zhang H, Shi J, Lin S, Liu C, Liu X, Zheng X, Chen Y, Deng L, Shi H.
    Int Immunopharmacol; 2024 Jul 30; 136():112332. PubMed ID: 38805776
    [Abstract] [Full Text] [Related]

  • 10. Nitro-fatty acid inhibition of triple-negative breast cancer cell viability, migration, invasion, and tumor growth.
    Woodcock CC, Huang Y, Woodcock SR, Salvatore SR, Singh B, Golin-Bisello F, Davidson NE, Neumann CA, Freeman BA, Wendell SG.
    J Biol Chem; 2018 Jan 26; 293(4):1120-1137. PubMed ID: 29158255
    [Abstract] [Full Text] [Related]

  • 11. Receptor-interacting protein kinase 2 promotes triple-negative breast cancer cell migration and invasion via activation of nuclear factor-kappaB and c-Jun N-terminal kinase pathways.
    Singel SM, Batten K, Cornelius C, Jia G, Fasciani G, Barron SL, Wright WE, Shay JW.
    Breast Cancer Res; 2014 Mar 19; 16(2):R28. PubMed ID: 24642040
    [Abstract] [Full Text] [Related]

  • 12. LncRNA ZFAS1 inhibits triple-negative breast cancer by targeting STAT3.
    Sharma U, Barwal TS, Khandelwal A, Malhotra A, Rana MK, Singh Rana AP, Imyanitov EN, Vasquez KM, Jain A.
    Biochimie; 2021 Mar 19; 182():99-107. PubMed ID: 33429003
    [Abstract] [Full Text] [Related]

  • 13. STAT3-induced NCK1 elevation promotes migration of triple-negative breast cancer cells via regulating ERK1/2 signaling.
    He P, Sheng J, Qi J, Bai X, Li J, Wang F, Yuan Y, Zheng X.
    Mol Biol Rep; 2022 Jan 19; 49(1):267-278. PubMed ID: 34846647
    [Abstract] [Full Text] [Related]

  • 14. Feline mammary basal-like adenocarcinomas: a potential model for human triple-negative breast cancer (TNBC) with basal-like subtype.
    Wiese DA, Thaiwong T, Yuzbasiyan-Gurkan V, Kiupel M.
    BMC Cancer; 2013 Sep 03; 13():403. PubMed ID: 24004841
    [Abstract] [Full Text] [Related]

  • 15. STAT3 and GR Cooperate to Drive Gene Expression and Growth of Basal-Like Triple-Negative Breast Cancer.
    Conway ME, McDaniel JM, Graham JM, Guillen KP, Oliver PG, Parker SL, Yue P, Turkson J, Buchsbaum DJ, Welm BE, Myers RM, Varley KE.
    Cancer Res; 2020 Oct 15; 80(20):4355-4370. PubMed ID: 32816914
    [Abstract] [Full Text] [Related]

  • 16. Extracellular matrix marker LAMC2 targets ZEB1 to promote TNBC malignancy via up-regulating CD44/STAT3 signaling pathway.
    Wang D, Keyoumu K, Yu R, Wen D, Jiang H, Liu X, Di X, Zhang S.
    Mol Med; 2024 May 17; 30(1):61. PubMed ID: 38760717
    [Abstract] [Full Text] [Related]

  • 17. RNA-binding protein NONO contributes to cancer cell growth and confers drug resistance as a theranostic target in TNBC.
    Kim SJ, Ju JS, Kang MH, Eun JW, Kim YH, Raninga PV, Khanna KK, Győrffy B, Pack CG, Han HD, Lee HJ, Gong G, Shin Y, Mills GB, Eyun SI, Park YY.
    Theranostics; 2020 May 17; 10(18):7974-7992. PubMed ID: 32724453
    [Abstract] [Full Text] [Related]

  • 18. DCAF13 promotes triple-negative breast cancer metastasis by mediating DTX3 mRNA degradation.
    Liu J, Li H, Mao A, Lu J, Liu W, Qie J, Pan G.
    Cell Cycle; 2020 Dec 17; 19(24):3622-3631. PubMed ID: 33300431
    [Abstract] [Full Text] [Related]

  • 19. Salidroside inhibits migration, invasion and angiogenesis of MDA‑MB 231 TNBC cells by regulating EGFR/Jak2/STAT3 signaling via MMP2.
    Kang DY, Sp N, Kim DH, Joung YH, Lee HG, Park YM, Yang YM.
    Int J Oncol; 2018 Aug 17; 53(2):877-885. PubMed ID: 29901185
    [Abstract] [Full Text] [Related]

  • 20. MicroRNA-544 down-regulates both Bcl6 and Stat3 to inhibit tumor growth of human triple negative breast cancer.
    Zhu Z, Wang S, Zhu J, Yang Q, Dong H, Huang J.
    Biol Chem; 2016 Oct 01; 397(10):1087-95. PubMed ID: 27186677
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.